Kcentra 1,000 unit vials
Ended Awarded
- Contract number
- SPE2DB25FZL39
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $9,857
Award facts
- Contract value 100% obligated
- $9,857.28 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $9,857.28 to DMS Pharmaceutical Group Inc. for 1,000 unit vials of Kcentra on September 29, 2025, with an ultimate completion date of October 21, 2025. This firm fixed-price delivery order was issued without a set-aside designation to the woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. Kcentra is a prothrombin complex concentrate used for urgent reversal of warfarin anticoagulation in patients with life-threatening bleeding, making it a critical pharmaceutical product for military healthcare facilities.
This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the Defense Logistics Agency valued at $499,999,999 through November 2026, which authorizes the agency to procure a comprehensive range of pharmaceutical products and medical supplies for Department of Defense healthcare systems. As an established federal pharmaceutical supplier since 2001, DMS Pharmaceutical Group has consistently demonstrated its capability to deliver specialized pharmaceutical products to military health facilities nationwide, supporting the DLA's mission to maintain adequate medical supply inventories across defense healthcare operations.
Quick answers
Who was awarded contract SPE2DB25FZL39?
SPE2DB25FZL39 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on September 29, 2025.
How much is contract SPE2DB25FZL39 worth?
The government has obligated $9,857 on SPE2DB25FZL39.
Is contract SPE2DB25FZL39 an order under another contract?
Yes. SPE2DB25FZL39 is a delivery order under SPE2DB20D9329, an indefinite delivery contract.
Was contract SPE2DB25FZL39 competed?
The extent of competition for SPE2DB25FZL39 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award